Reports and presentations


“Selvita S.A. Financial results 2018A and development plans”

“Selvita Oncology Corporate Presentation – May 2019”


As a publicly listed company (WSE: SLV) Selvita is regularly analyzed and valued by several analysts from brokerage houses. Currently published target prices for the Company shares are available here:  Investor Center.



Furthermore, in March 2014, Selvita initiated cooperation with Edison Investment Research, a global investment intelligence firm, which regularly prepares comprehensive analysis and valuation of the Company.

The scope of cooperation includes preparation by Edison Investment Research reports containing detailed analysis of products, and services, as well as financial analysis, forecasts and valuation of the Company.

A complete list of published reports is available at Edison Investment Research.